Activity limitations | Level I β (95% CI) | Level II β (95% CI) | Level III β (95% CI) |
---|---|---|---|
Personal factor | Â | Â | Â |
Age | 0.54***(0.19, 0.33) | 0.39***(0.11, 0.26) | 0.26**(0.05, 0.20) |
Regular exercise (yes) | -0.24**(-2.59, -0.55) | -0.19*(-2.22, -0.27) | -0.12(-1.72, 0.17) |
Perceived health status | -0.23**(-0.79, -0.16) | -0.21**(-0.73, -0.14) | -0.20**(-0.70, -0.11) |
Function/structure factors | Â | Â | Â |
Neuropathy (yes) | Â | 0.12(-0.18, 1.84) | 0.13(-0.04, 1.86) |
MMSE | Â | -0.25**(-0.43, -0.11) | -0.22**(-0.38, -0.08) |
GDS-S | Â | 0.11(-0.04, 0.26) | 0.01(-0.16, 0.17) |
Environmental factors | Â | Â | Â |
PPS | Â | Â | -0.29***(-0.31, -0.10) |
NPS | Â | Â | 0.08(-0.07, 0.19) |
Missing samples (yes) | Â | Â | 0.08(-0.56, 1.79) |
R 2 | 0.40 | 0.49 | 0.56 |
Adjusted R2 | 0.38 | 0.46 | 0.53 |
Increase in R2 | 0.40 | 0.09 | 0.07 |
 F Change | 23.17*** | 6.09** | 5.88** |
Participation restrictions | Level I β (95% CI) | Level II β (95% CI) | Level III β (95% CI) |
Personal factors | Â | Â | Â |
Age | 0.37***(0.04, 0.12) | 0.28**(0.02, 0.10) | 0.17(-0.01, 0.08) |
Dietary control (yes) | -0.16(-1.02, 0.04) | -0.09(-0.81, 0.25) | -0.10(-0.80, 0.21) |
Function/structure factors | Â | Â | Â |
Neuropathy (yes) | Â | 0.11(-0.23, 0.90) | 0.11(-0.20, 0.88) |
GDS-S | Â | 0.29**(0.06, 0.22) | 0.22*(0.01, 0.19) |
Environmental factors | Â | Â | Â |
PPS | Â | Â | -0.28**(-0.15, -0.03) |
NPS | Â | Â | -0.04(-0.08, 0.05) |
Missing samples (yes) | Â | Â | 0.09(-0.32, 0.95) |
R 2 | 0.17 | 0.27 | 0.35 |
Adjusted R2 | 0.16 | 0.24 | 0.30 |
Increase in R2 | 0.17 | 0.93 | 0.79 |
 F Change | 11.28*** | 6.69** | 4.10** |